Stargate CEOs cite project’s promise of enabling cancer vaccines, though Musk joins critics in questioning partners’ ...

Merck and Eisai report mixed results from LEAP-015 trial of Keytruda and Lenvima in HER2-negative gastroesophageal cancer treatment.

The CEO of Germany's Merck KGaA said a recovery in sales growth at its existing business means it can take a cautious approach when it comes to buying other companies, which are expensively priced.

Jefferies raised the firm’s price target on Henry Schein (HSIC) to $80 from $77 and keeps a Hold rating on the shares. Management has a strong ...

In a report released on January 21, Akash Tewari from Jefferies reiterated a Buy rating on Merck & Company (MRK – Research Report). The ...

We recently compiled a list of the 15 Best Large-Cap Value Stocks to Buy in 2025. In this article, we are going to take a ...

We recently compiled a list of the 15 Stocks to Invest in with Steady Dividends. In this article, we are going to take a look ...

Needham initiated a Buy rating for Absci (ABSI), noting its AI-powered drug discovery platforms, strategic partnerships, and ...

Decided to add this retail giant to your portfolio? Here's what you need to know before buying Amazon stock. Many, or all, of the products featured on this page are from our advertising partners ...

Shares of Summit Therapeutics ( SMMT 4.80%) had jumped 14.3% at 11:31 a.m. ET on Tuesday. The nice gain came after reports ...

Deutsche Bank analyst Edison Yu raised his rating on GM stock to Buy from Hold, and lifted his price target to $60 from $56.

Discover why Merck presents a compelling long-term investment opportunity with its discounted valuation, robust pipeline, and ...